Analysts' average 12-month price target for Phreesia is $13.
Get informed when a big investor buys or sells
+ Follow$10
7 analysts in the last 4 months
High: $16 | Low: $10
No recommendations in the last 4 months.
Phreesia (PHR) currently reports a target price of $13. Use the charts on this page to explore Phreesia's target price history and peer comparisons.
Analysts' average 12-month price target for Phreesia is $13, about 25.7% upside from the current share price of $10.0. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $13, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phreesia, and consider following PHR for alerts when major investors trade the stock.
Phreesia is classified in the Healthcare sector. On target price, it currently shows $13. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHR with unrelated industries.